A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

BACKGROUND: Prostate-specific antigen (PSA) is widely used to detect prostate cancer. The low positive predictive value of elevated PSA results in large numbers of unnecessary prostate biopsies. We set out to determine whether a multivariable model including four kallikrein forms (total, free, and i...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Vickers, Andrew J, Cronin, Angel M, Aus, Gunnar, Pihl, Carl-Gustav, Becker, Charlotte, Pettersson, Kim, Scardino, Peter T, Hugosson, Jonas, Lilja, Hans
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2008
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2474851/
https://ncbi.nlm.nih.gov/pubmed/18611265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-6-19
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki